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Abstract
Purpose: to demonstrate 1H-MR spectroscopy of the frontal region in patients with metabolic syndrome and to correlate 
the metabolic ratios with anthropometric measurement.
Material and methods: A prospective study was conducted upon 20 patients with metabolic syndrome (10 male, 10 female; 
mean age 52 years) and 20 age- and sex-matched volunteers. Patients were mild-moderate (n = 14) and marked and 
morbid obesity (n = 6). Patients and volunteers underwent 1H-MR spectroscopy of the frontal region. The Ch/Cr and 
NAA/Cr ratio were calculated and correlated with anthropometric measurement. 
Results: The Cho/Cr and NAA/Cr of patients with Mets (1.03 ± 0.08 and 1.62 ± 0.08) were significantly different  
(p = 0.001) to those of volunteers (0.78 ± 0 and 1.71 ± 0.61, respectively). The Cho/Cr and NAA/Cr cutoffs used to 
differentiate patients from volunteers were 0.89 and 1.77 with areas under the curve of 0.992 and 0.867 and accura-
cy of 97% and 93%, respectively. There was a significant difference in Cho/Cr and NAA/Cr between patients with 
marked-morbid obesity and moderate-mild obesity (p = 0.001 respectively). 
Conclusions: We concluded that NAA/Cr and Cho/Cr ratios of the frontal region can differentiate patients with metabolic 
syndrome from volunteers and are well correlated with the anthropometric measurement.
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Introduction
Metabolic syndrome refers to the co-occurrence of 
several known cardiovascular risk factors, including in-
sulin resistance, obesity, atherogenic dyslipidaemia, and 
high blood pressure. Metabolic syndrome may be im-
portant in the development of age-related cognitive de-
cline, mild cognitive impairment, vascular dementia, and 
Alzheimer’s disease [1-4]. Various imaging modalities are 
used to study the effect of metabolic syndrome on brain 
parenchyma. Magnetic resonance imaging studies includ-
ing 1H-MR spectroscopy, magnetisation transfer ratios, 
voxel-based morphometry, and diffusion tensor imaging 
have been used to understand cerebral alterations of pa-
tients with metabolic syndrome [5-9]. The 1H-MR spec-
troscopy is diagnostic non-invasive imaging that offers 
the possibility of detecting and quantifying different me-
tabolites of the brain [10-13]. Few studies are discussing 
the role of 1H-MR spectroscopy in assessment of meta-
bolic changes of the brain in patients with metabolic syn-
drome [14-18].
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The aim of this work is to demonstrate the role of 
1H-MR spectroscopy of the frontal region in patients with 
metabolic syndrome and to correlate metabolic changes 
with anthropometric measurements.
Material and methods
Patients
Institutional board approval for the study and informed 
consent from each patient and volunteer was obtained. 
This prospective study was done on 23 adult patients with 
metabolic syndrome. The inclusion criteria were patients 
with metabolic syndrome diagnosed according to Inter-
national Diabetes Federation [19]. We excluded three pa-
tients with diabetes mellitus. The final study group com-
posed of 20 patients with Mets (10 male, 10 female; aged 
45-60 years, mean 52 years), who underwent routine MR 
imaging and 1H-MR spectroscopy of the brain. Twenty 
age- and sex-matched healthy volunteers (10 male and 
10 female; age range 45-60 years) were included as a con-
trol group. All patients and controls had excluded all dis-
eases that can affect the central nervous system.
Magnetic resonance imaging
MR imaging was performed using a 1.5-tesla scan-
ner and a commercially available circularly polarised 
head coil. MR imaging consisted of transverse T1- and 
T2-weighted imaging. The imaging parameters were TR/
TE 500/14 ms for T1-weighted images and 5000/86 ms for 
T2-weighted images; field of view (FOV) 240 × 240 mm; 
section thickness 5 mm and intersection gap 0.5 mm. 
The homogeneity of the magnetic field over the volume 
of interest was optimised by shimming. Suppression of 
the water signal was performed by using three preced-
ing Gaussian pulses (60-Hz bandwidth). A single voxel 
point-resolved spectroscopy pulse sequence (PRESS) 
technique was applied using the following parameters: 
TR/TE 1500/35 ms, voxel size 8 cm3, and number of aver-
ages 128. A voxel of 3 × 3 × 3 cm3 was located in the white 
matter of the left frontal region. A standard software pack-
age was used for post processing MR spectroscopic data. 
Image analysis
Analysis of 1H-MR spectroscopy was performed by 
only one radiologist with 20 years of experience in MR 
imaging, and he was blinded to the clinical and laboratory 
findings of the patients. The images were transferred to 
a workstation (extended MR Workspace 2.6.3.5, Philips 
Medical Systems Nederland). Assignment of the reso-
nance peaks of N-acetyl-aspartate (NAA) at 2.02 ppm, 
creatine (Cr) at 3.03 ppm and 3.9 ppm, and choline (Ch) 
at 3.2 ppm were determined by fit and integration of the 
resonance in the post-processed Fourier spectra. The in-
tegrals of Cho, Cr were calculated. The metabolite ratios 
of NAA/Cr and Ch/Cr were calculated.
Statistical analysis 
The statistical analysis of data was done by using Sta-
tistical Package for Social Science version 16.0 (SPSS Inc., 
Chicago, Ill, USA). The mean and standard deviation of 
NAA/Cr and Cho/Cr of patients and volunteers were cal-
culated. The analysis of data was done to test the statistical 
significant difference. Independent sample (student-t test) 
and one-way ANOVA were done to study the difference 
of the metabolite ratios between patients and volunteers. 
The p value was considered significant when ≤ 0.05. A re-
ceiver operating characteristic (ROC) curve was com-
pleted to evaluate the diagnostic capability of NAA/Cr 
and Cho/Cr for differentiation of patients with metabol-
ic syndrome from volunteers. The area under the curve, 
sensitivity, specificity, and accuracy were calculated. Pear-
son’s correlation test was done to correlate NAA/Cr and 
Cho/Cr with anthropometric measurements. The correla-
tion coefficient r and p value were calculated.
Results
Table 1 shows the metabolic ratios of 1H-MR spec-
troscopy of patients and volunteers. Table 2 shows the re-
ceiver operating characteristic curve of metabolites ratio 
used to differentiate patients from volunteers. Figure 1 
shows the 1H-MR spectroscopy of patients with metabolic 
syndrome and volunteers. 
The mean Cho/Cr ratio of the frontal region in pa-
tients with metabolic syndrome was 1.03 ± 0.08 and in 
volunteers was 0.78 ± 0.0.05. The cutoff Cho/Cr used to 
differentiate patients with metabolic syndrome from vol-
unteers was ≥ 0.895 with an area under the curve of 0.992, 
sensitivity of 100.0%, specificity of 93.3%, and accuracy 
of 97.0%. The mean NAA/Cr ratio of the frontal region 
in patients with metabolic syndrome was 1.62 ± 0.08 and 
in volunteers was 1.71 ± 0.61. The cutoff NAA/Cr used to 
differentiate patients with metabolic syndrome from vol-
Table 1. The metabolic ratios at magnetic resonance spectroscopy of pa-
tients and volunteers
Metabolites Patients Volunteers p value
Ch/Cr 1.03 ± 0.08 0.78 ± 0.05 0.001
NAA/Cr 1.62 ± 0.08 1.71 ± 0.61 0.404
Table 2. The receiver operating characteristic curve of metabolites in pa-
tients with Mets
Meta-
bolites
Cutoff 
point
AUC Sensitivity Specificity Accuracy
Ch/Cr 0.992 0.895 96.7% 100.0% 98.0%
NAA/Cr 0.867 1.77 100.0% 86.7% 93.0%
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unteers was ≤ 1.77 with an area under the curve of 0.867, 
sensitivity of 100.0%, specificity of 86.7%, and accuracy of 
93.0% (Figure 2, Table 2).
Patients were mild-moderate (n =14) and marked and 
morbid obesity (n = 6). The mean Cho/Cr of the frontal 
region was 1.09 ± 0.09 and 0.98 ± 0.03 in severe and mild 
obesity, respectively. The mean NAA/Cr ratio in the fron-
tal region was 1.56 ± 0.07 and 1.67 ± 0.03 in severe and 
mild obesity, respectively (Table 3). There was a statistical-
ly significant difference in brain metabolite ratios between 
patients with severe obesity and patients with mild obesity 
(p = 0.001).
Discussion
The main findings in this study is that there is a signif-
icant difference in the brain metabolite ratios of patients 
with metabolic syndrome compared to volunteers, and pa-
tients with severe obesity compared to mild obesity. There 
is a correlation of brain metabolite ratios with anthropo-
metric measures in patients with metabolic syndrome.
In this study, the mean metabolite ratios of the frontal 
region in patients with metabolic syndrome were different 
than that of volunteers. This may be attributed to visceral 
obesity, insulin resistance, atherogenic dyslipidaemia, and 
endothelial dysfunction, as well as a constellation of inde-
pendent factors (e.g. molecules of hepatic, vascular, and 
immunological origin) that mediate specific components 
of the metabolic syndrome. A number of theories have 
Figure 1. Magnetic resonance (MR) spectrum of frontal region. A) MR spectroscopy of the frontal region in patients with metabolic syndrome 
(NAA/Cr = 1.63, Ch/Cr = 1.07). B) MR spectroscopy of the frontal region in healthy volunteers (NAA/Cr = 1.71, Ch/Cr = 0.78)
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Figure 2. Receiver operating characteristic (ROC) curve of patients versus volunteers. A) The cutoff Cho/Cr of the frontal region used to differentiate patients 
with metabolic syndrome from volunteers was ≥ 0.895 with an area under the curve of 0.992, sensitivity of 100.0%, specificity of 93.3%, and accuracy of 
97.0%. B) The cutoff NAA/Cr of the frontal lobe used to differentiate patients with metabolic syndrome from volunteers was ≤ 1.77 with an area under the 
curve of 0.867, sensitivity of 100.0%, specificity of 86.7%, and accuracy of 93.0%
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Table 3. The metabolic ratios at magnetic resonance spectroscopy of pa-
tients with mild and morbid obesity
Metabolites Mild obesity Morbid obesity p value
Ch/Cr 0.98 ± 0.03 1.09 ± 0.09 0.001
NAA/Cr 1.67 ± 0.03 1.56 ± 0.07 0.001
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been proposed for the ill effects of metabolic syndrome 
on the brain and cognition, including neuro-inflamma-
tion, oxidative stress, abnormal brain lipid metabolism, 
and impaired vascular reactivity [9].
In this study, there was decreased NAA/Ch ratio of 
the frontal region in patients compared to volunteers. 
The NAA is an amino acid that is exclusively synthesised 
and localised in neurons. It acts as a major osmolyte 
and serves as a marker of neuronal viability. The prima-
ry role of NAA is neuronal-glial cell specific signalling 
for optimal functioning of the central nervous system. 
The decline in brain NAA reflects axonal or neuronal dys-
function or loss in neuronal density [10, 11]. Lower NAA 
is consistent with derangement of neurometabolism, low-
er dendritic/axonal density, and/or axonal loss. Decreased 
NAA might be indicative of decreased neuronal viability 
in metabolic syndrome as a result of chronic hypoxia and 
hyperglycaemia [14-18].
In this study, the Cho/Cr ratio was higher in patients 
than in volunteers. Previous studies reported that cho-
line-containing compounds are an indicator of cell den-
sity and cell wall turnover. They also reflect metabolism 
of myelin and other phospholipids of the cell membrane 
[10-14]. The high choline level of the frontal white matter 
suggests membrane and/or myelin alterations and/or al-
terations in membrane turnover. Thus, these results point 
to axonal and myelin abnormalities of the frontal white 
matter, as well as decreased neuronal viability in the fron-
tal lobe [14-17].
In this study, there was a decrease in NAA/Cr levels 
and an increase in the Cho/Cr ratio in patients with se-
vere morbid obesity compared to mild-moderate obesity. 
This is attributed to the fact that obesity contributes to 
hypertension, high serum cholesterol, low HDL cholester-
ol, and hyperglycaemia. Visceral obesity causes a decrease 
in insulin-mediated glucose uptake and is clearly related 
to insulin resistance. The mechanisms for this proba-
bly involve adipokines (made by adipose tissue), which 
modulate crosstalk between metabolism and vascular 
function [1-5].
This study has some limitations. First, the small 
number of patients limits the ability to achieve statisti-
cally significant results. However, further multi-centre 
studies upon a larger number of patients with metabolic 
syndrome are recommended. Second, this study applied 
single-voxel proton MR spectroscopy of the brain. Fur-
ther studies with application of multi-parametric imag-
ing of the brain combined with diffusion-weighted MR 
imaging [20-22], diffusion tensor MR imaging [23, 24], 
and dynamic contrast MR imaging [25-27] with a higher 
three-tesla machine [28-31] may provide better results. 
Conclusions
We conclude that the NAA/Cr and Cho/Cr ratios of 
the frontal region can differentiate patients with metabolic 
syndrome from healthy volunteers and are well correlated 
with anthropometric measures.
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